Comparison between Anand Rayons IPO and Par Drugs IPO.
Anand Rayons IPO is a SME Fixed Price IPO proposed to list at BSE SME while Par Drugs IPO is a SME Fixed Price proposed to list at NSE SME.
| Anand Rayons IPO | Par Drugs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Oneview Corporate Advisors Pvt.Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Basan Equity Broking Ltd. | Pantomath Stock Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Anand Rayons IPO is up to ₹12.01 Cr whereas the issue size of the Par Drugs IPO is up to ₹8.10 Cr. The final issue price of Anand Rayons IPO is ₹27.00 per share and of Par Drugs IPO is ₹51.00 per share.
| Anand Rayons IPO | Par Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹27.00 per share | ₹51.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 4000 shares | 2000 shares |
| Fresh Issue Size | 44,48,000 shares | 15,88,000 shares |
| Fresh Issue Size (Amount) | up to ₹12.01 Cr | up to ₹8.10 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 44,48,000 shares | 15,88,000 shares |
| Issue Size Total (Amount) | up to ₹12.01 Cr | up to ₹8.10 Cr |
Anand Rayons IPO opens on Jun 18, 2019, while Par Drugs IPO opens on May 03, 2019. The closing date of Anand Rayons IPO and Par Drugs IPO is Jun 24, 2019, and May 08, 2019, respectively.
| Anand Rayons IPO | Par Drugs IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 18, 2019 | May 03, 2019 |
| Issue Close | Jun 24, 2019 | May 08, 2019 |
| Basis Of Allotment (Tentative) | May 13, 2019 | |
| Initiation of Refunds (Tentative) | Jun 28, 2019 | May 14, 2019 |
| Credit of Share (Tentative) | Jul 01, 2019 | May 15, 2019 |
| Listing date (Tentative) | Jul 02, 2019 | May 16, 2019 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Anand Rayons IPO P/E ratio is , as compared to Par Drugs IPO P/E ratio of .
| Anand Rayons IPO | Par Drugs IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.55 | |||||
| Promoter Shareholding (Post-Issue) | 72.82 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹40.46 Cr. | ₹31.38 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Anand Rayons IPO Retail Individual Investors (RII) are offered 22,24,000 shares while in Par Drugs IPO retail investors are offered 22,24,000 shares. Qualified Institutional Buyers (QIB) are offered in Anand Rayons IPO and in Par Drugs IPO.
| Anand Rayons IPO | Par Drugs IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 2,40,000 shares | 84,000 shares |
| QIB | ||
| NII | 22,24,000 shares | 7,78,000 shares |
| RII | 22,24,000 shares | 7,80,000 shares |
| Employee | 30,000 shares | |
| Others | ||
| Total | 44,48,000 shares | 15,88,000 shares |
Anand Rayons IPO subscribed 1.17x in total, whereas Par Drugs IPO subscribed 5.64x.
| Anand Rayons IPO | Par Drugs IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.86x | 3.48x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.48x | 7.97x |
| Employee (times) | 1.00x | |
| Other (times) | ||
| Total (times) | 1.17x | 5.64x |
